Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disclosing a misdiagnosis of multiple sclerosis: do no harm?
A proposed roadmap for inpatient neurology quality indicators.
Epstein-Barr virus in oral shedding of children with multiple sclerosis.
Evaluation of clinical parameters during and after treatment of attack in patients with clinically isolated syndrome: Comparison of the results with that of multiple sclerosis patients.
P300 wave changes in patients with multiple sclerosis.
Electrophysiological Evaluation of Chronic Inflammatory Demyelinating Polyneuropathy and Charcot-Marie-Tooth Type 1: Dispersion and Correlation Analysis.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.
Neuromyelitis optica spectrum disorders: An update.
Unveiling the anti-inflammatory activity of Sutherlandia frutescens using murine macrophages.
Restless legs syndrome in multiple sclerosis.
Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
Effect of spasticity on kinematics of gait and muscular activation in people with Multiple Sclerosis.
Effectiveness of muscle basal lamina carrying neural stem cells and olfactory ensheathing cells in spinal cord repair.
Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica.
Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.
Composite end points to assess delay of disability progression by MS treatments.
Diagnosis of asymptomatic natalizumab-associated PML: are we between a rock and a hard place?
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible?
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.

Pages